Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Qinlan oral solution
- Development stage
- Unknown
- Lead developer
- Heilongjiang ZBD Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fufang Qinlan oral solution is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of acute upper respiratory tract infections, specifically those diagnosed as wind-heat common cold in TCM theory. Developed and manufactured by companies such as Heilongjiang Zhenbaodao Pharmaceutical and Heilongjiang Yudi Pharmaceutical, the solution typically contains extracts from *Scutellaria baicalensis* (Huangqin), *Isatis indigotica* (Banlangen), and *Forsythia suspensa* (Lianqiao). These botanical ingredients are traditionally recognized for their heat-clearing, detoxifying, and anti-inflammatory properties. The drug is currently being evaluated in Phase II clinical trials in China for pediatric use to assess its efficacy and safety in children aged 4–12 years with acute upper respiratory tract infections.
- Brand names
- Fufang Qinlan oral solution
- Other names
- 复方芩兰口服液
Beyond the preview
Go deeper on Fufang Qinlan oral solution.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fufang Qinlan oral solution.